Skip to main content
Erschienen in: American Journal of Clinical Dermatology 6/2021

01.09.2021 | Review Article

The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation

verfasst von: Nada Elbuluk, Pearl Grimes, Anna Chien, Iltefat Hamzavi, Andrew Alexis, Susan Taylor, Noelani Gonzalez, Jonathan Weiss, Seemal R. Desai, Sewon Kang

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Acne vulgaris is a common inflammatory disease. Among patients with darker skin phototypes (Fitzpatrick III–VI), the inflammatory processes of acne stimulate excess melanogenesis and abnormal melanin deposition, leading to pigmentary sequelae known as post-inflammatory hyperpigmentation and post-inflammatory erythema in all skin tones, although post-inflammatory hyperpigmentation is more common in darker skin and post-inflammatory erythema in lighter skin. These pigmentary alterations can be long lasting and are often more distressing to patients than the active acne lesions. This article discusses what is known about acne-related pigmentation, much of which is extrapolated from general study of nonspecific pigment deposition. Because dyspigmentation poses both a significant clinical concern to patients and a therapeutic challenge to clinicians, we formed a working group consisting of pigmentary experts with the aim of increasing awareness and education of acne-related pigmentary sequelae.
Literatur
1.
Zurück zum Zitat Alexis AF, Lamb A. Concomitant therapy for acne in patients with skin of color: a case-based approach. Dermatol Nurs. 2009;21:33–6.PubMed Alexis AF, Lamb A. Concomitant therapy for acne in patients with skin of color: a case-based approach. Dermatol Nurs. 2009;21:33–6.PubMed
2.
Zurück zum Zitat Halder RM, Brooks HL, Callender VD. Acne in ethnic skin. Dermatol Clin. 2003;21(609–15):vii. Halder RM, Brooks HL, Callender VD. Acne in ethnic skin. Dermatol Clin. 2003;21(609–15):vii.
3.
Zurück zum Zitat Halder RM, Grimes PE, McLaurin CI, Kress MA, Kenney JA Jr. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32(388):390. Halder RM, Grimes PE, McLaurin CI, Kress MA, Kenney JA Jr. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32(388):390.
4.
Zurück zum Zitat Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermatol Clin. 2003;21:601–7.PubMedCrossRef Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermatol Clin. 2003;21:601–7.PubMedCrossRef
5.
Zurück zum Zitat Abad-Casintahan F, Chow SK, Goh CL, et al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):926–8.CrossRef Abad-Casintahan F, Chow SK, Goh CL, et al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):926–8.CrossRef
6.
Zurück zum Zitat Goh CL, Abad-Casintahan F, Chow SK, et al. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts. J Dermatol. 2014;41:1106–8.PubMedCrossRef Goh CL, Abad-Casintahan F, Chow SK, et al. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts. J Dermatol. 2014;41:1106–8.PubMedCrossRef
7.
Zurück zum Zitat Gollnick H, Abanmi AA, Al-Enezi M, et al. Managing acne in the Middle East: consensus recommendations. J Eur Acad Dermatol Venereol. 2017;31(Suppl. 7):4–35.PubMedCrossRef Gollnick H, Abanmi AA, Al-Enezi M, et al. Managing acne in the Middle East: consensus recommendations. J Eur Acad Dermatol Venereol. 2017;31(Suppl. 7):4–35.PubMedCrossRef
8.
Zurück zum Zitat Abanmi AA, Al-Enezi M, Al Hammadi A, Galadari I, Kibbi A-G, Zimmo S. Progress and problems with acne management in the Middle East. Gulf J Dermatol Venereol. 2016;23:1–5. Abanmi AA, Al-Enezi M, Al Hammadi A, Galadari I, Kibbi A-G, Zimmo S. Progress and problems with acne management in the Middle East. Gulf J Dermatol Venereol. 2016;23:1–5.
9.
Zurück zum Zitat Callender VD, Barbosa V, Burgess CM, et al. Approach to treatment of medical and cosmetic facial concerns in skin of color patients. Cutis. 2017;100:375–80.PubMed Callender VD, Barbosa V, Burgess CM, et al. Approach to treatment of medical and cosmetic facial concerns in skin of color patients. Cutis. 2017;100:375–80.PubMed
10.
Zurück zum Zitat Kang SJ, Davis SA, Feldman SR, McMichael AJ. Dyschromia in skin of color. J Drugs Dermatol. 2014;13:401–6.PubMed Kang SJ, Davis SA, Feldman SR, McMichael AJ. Dyschromia in skin of color. J Drugs Dermatol. 2014;13:401–6.PubMed
11.
Zurück zum Zitat Davis SA, Narahari S, Feldman SR, Huang W, Pichardo-Geisinger RO, McMichael AJ. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11:466–73.PubMed Davis SA, Narahari S, Feldman SR, Huang W, Pichardo-Geisinger RO, McMichael AJ. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11:466–73.PubMed
12.
Zurück zum Zitat Min S, Park SY, Yoon JY, Kwon HH, Suh DH. Fractional microneedling radiofrequency treatment for acne-related post-inflammatory erythema. Acta Derm Venereol. 2016;96:87–91.PubMedCrossRef Min S, Park SY, Yoon JY, Kwon HH, Suh DH. Fractional microneedling radiofrequency treatment for acne-related post-inflammatory erythema. Acta Derm Venereol. 2016;96:87–91.PubMedCrossRef
13.
Zurück zum Zitat Tan J, Bourdes V, Bissonnette R, et al. Prospective study of pathogenesis of atrophic acne scars and role of macular erythema. J Drugs Dermatol. 2017;16:566–72.PubMed Tan J, Bourdes V, Bissonnette R, et al. Prospective study of pathogenesis of atrophic acne scars and role of macular erythema. J Drugs Dermatol. 2017;16:566–72.PubMed
15.
Zurück zum Zitat Akinboro AO, Ezejiofor OI, Olanrewaju FO, et al. The impact of acne and facial post-inflammatory hyperpigmentation on quality of life and self-esteem of newly admitted Nigerian undergraduates. Clin Cosmet Investig Dermatol. 2018;11:245–52.PubMedPubMedCentralCrossRef Akinboro AO, Ezejiofor OI, Olanrewaju FO, et al. The impact of acne and facial post-inflammatory hyperpigmentation on quality of life and self-esteem of newly admitted Nigerian undergraduates. Clin Cosmet Investig Dermatol. 2018;11:245–52.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Abanmi A, Al-Enezi M, Al Hammadi A, Galadari I, Kibbi AG, Zimmo S. Survey of acne-related post-inflammatory hyperpigmentation in the Middle East. J Dermatolog Treat. 2019;30:578–81.PubMedCrossRef Abanmi A, Al-Enezi M, Al Hammadi A, Galadari I, Kibbi AG, Zimmo S. Survey of acne-related post-inflammatory hyperpigmentation in the Middle East. J Dermatolog Treat. 2019;30:578–81.PubMedCrossRef
17.
Zurück zum Zitat Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19:303–8.PubMedCrossRef Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19:303–8.PubMedCrossRef
18.
Zurück zum Zitat Kane A, Niang SO, Diagne AC, Ly F, Ndiaye B. Epidemiologic, clinical, and therapeutic features of acne in Dakar. Senegal Int J Dermatol. 2007;46(Suppl. 1):36–8.PubMedCrossRef Kane A, Niang SO, Diagne AC, Ly F, Ndiaye B. Epidemiologic, clinical, and therapeutic features of acne in Dakar. Senegal Int J Dermatol. 2007;46(Suppl. 1):36–8.PubMedCrossRef
19.
Zurück zum Zitat Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3:20–31.PubMedPubMedCentral Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3:20–31.PubMedPubMedCentral
20.
21.
Zurück zum Zitat Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20–7.PubMedCrossRef Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20–7.PubMedCrossRef
22.
Zurück zum Zitat Norris JF, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 1988;118:651–9.PubMedCrossRef Norris JF, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 1988;118:651–9.PubMedCrossRef
23.
Zurück zum Zitat Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77:591–605.PubMedCrossRef Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77:591–605.PubMedCrossRef
24.
Zurück zum Zitat Adalatkhah H, Sadeghi BH. The association between melasma and postinflammatory hyperpigmentation in acne patients. Iran Red Crescent Med J. 2013;15:400–3.PubMedPubMedCentralCrossRef Adalatkhah H, Sadeghi BH. The association between melasma and postinflammatory hyperpigmentation in acne patients. Iran Red Crescent Med J. 2013;15:400–3.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Nordlund JJB, Hearing VJ, King RA, Oetting W, Ortonne JP. The pigmentary system: physiology and pathophysiology. Malden: Blackwell Publishing; 2006.CrossRef Nordlund JJB, Hearing VJ, King RA, Oetting W, Ortonne JP. The pigmentary system: physiology and pathophysiology. Malden: Blackwell Publishing; 2006.CrossRef
26.
Zurück zum Zitat Cayce KA, McMichael AJ, Feldman SR. Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs. 2004;16:401–6.PubMed Cayce KA, McMichael AJ, Feldman SR. Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs. 2004;16:401–6.PubMed
27.
Zurück zum Zitat Isedeh P, Kohli I, Al-Jamal M, et al. An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits. Br J Dermatol. 2016;174:862–8.PubMedCrossRef Isedeh P, Kohli I, Al-Jamal M, et al. An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits. Br J Dermatol. 2016;174:862–8.PubMedCrossRef
28.
Zurück zum Zitat Nordlund JJA-M, Abdel-Malek ZA. Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. In: Bagnara JT, editor. Thirteenth international pigment. Tucson: Liss; 1986. p. 219–39. Nordlund JJA-M, Abdel-Malek ZA. Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. In: Bagnara JT, editor. Thirteenth international pigment. Tucson: Liss; 1986. p. 219–39.
29.
Zurück zum Zitat Ebanks JP, Wickett RR, Boissy RE. Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. Int J Mol Sci. 2009;10:4066–87.PubMedPubMedCentralCrossRef Ebanks JP, Wickett RR, Boissy RE. Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. Int J Mol Sci. 2009;10:4066–87.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Del Bino S, Duval C, Bernerd F. Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact. Int J Mol Sci. 2018;19:2668.PubMedCentralCrossRef Del Bino S, Duval C, Bernerd F. Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact. Int J Mol Sci. 2018;19:2668.PubMedCentralCrossRef
31.
Zurück zum Zitat Shin JWP, Park KC. Current clinical use of depigmenting agents. Dermatol Sin. 2014;32:205–10.CrossRef Shin JWP, Park KC. Current clinical use of depigmenting agents. Dermatol Sin. 2014;32:205–10.CrossRef
32.
Zurück zum Zitat D’Mello SA, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling pathways in melanogenesis. Int J Mol Sci. 2016;17(7):1144.PubMedCentralCrossRef D’Mello SA, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling pathways in melanogenesis. Int J Mol Sci. 2016;17(7):1144.PubMedCentralCrossRef
33.
Zurück zum Zitat Shah SK, Alexis AF. Acne in skin of color: practical approaches to treatment. J Dermatol Treat. 2010;21:206–11.CrossRef Shah SK, Alexis AF. Acne in skin of color: practical approaches to treatment. J Dermatol Treat. 2010;21:206–11.CrossRef
34.
Zurück zum Zitat Chaowattanapanit S, Silpa-Archa N, Kohli I, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J Am Acad Dermatol. 2017;77:607–21.PubMedCrossRef Chaowattanapanit S, Silpa-Archa N, Kohli I, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J Am Acad Dermatol. 2017;77:607–21.PubMedCrossRef
35.
Zurück zum Zitat Palumbo A, d’Ischia M, Misuraca G, Prota G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta. 1991;1073:85–90.PubMedCrossRef Palumbo A, d’Ischia M, Misuraca G, Prota G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta. 1991;1073:85–90.PubMedCrossRef
36.
Zurück zum Zitat Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10:586–90.PubMed Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol. 2011;10:586–90.PubMed
37.
Zurück zum Zitat Sarkar R, Ghunawat S, Garg VK. Comparative study of 35% glycolic acid, 20% salicylic-10% mandelic acid, and phytic acid combination peels in the treatment of active acne and postacne pigmentation. J Cutan Aesthet Surg. 2019;12:158–63.PubMedPubMedCentralCrossRef Sarkar R, Ghunawat S, Garg VK. Comparative study of 35% glycolic acid, 20% salicylic-10% mandelic acid, and phytic acid combination peels in the treatment of active acne and postacne pigmentation. J Cutan Aesthet Surg. 2019;12:158–63.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Chan HH, Manstein D, Yu CS, Shek S, Kono T, Wei WI. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med. 2007;39:381–5.PubMedCrossRef Chan HH, Manstein D, Yu CS, Shek S, Kono T, Wei WI. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med. 2007;39:381–5.PubMedCrossRef
39.
Zurück zum Zitat Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol. 2013;169(Suppl. 3):91–7.PubMedCrossRef Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol. 2013;169(Suppl. 3):91–7.PubMedCrossRef
40.
Zurück zum Zitat Bae YC, Rettig S, Weiss E, Bernstein L, Geronemus R. Treatment of post-inflammatory hyperpigmentation in patients with darker skin types using a low energy 1,927 nm non-ablative fractional laser: a retrospective photographic review analysis. Lasers Surg Med. 2020;52:7–12.PubMedCrossRef Bae YC, Rettig S, Weiss E, Bernstein L, Geronemus R. Treatment of post-inflammatory hyperpigmentation in patients with darker skin types using a low energy 1,927 nm non-ablative fractional laser: a retrospective photographic review analysis. Lasers Surg Med. 2020;52:7–12.PubMedCrossRef
41.
Zurück zum Zitat Haimovic A, Brauer JA, Cindy Bae YS, Geronemus RG. Safety of a picosecond laser with diffractive lens array (DLA) in the treatment of Fitzpatrick skin types IV to VI: a retrospective review. J Am Acad Dermatol. 2016;74:931–6.PubMedCrossRef Haimovic A, Brauer JA, Cindy Bae YS, Geronemus RG. Safety of a picosecond laser with diffractive lens array (DLA) in the treatment of Fitzpatrick skin types IV to VI: a retrospective review. J Am Acad Dermatol. 2016;74:931–6.PubMedCrossRef
Metadaten
Titel
The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation
verfasst von
Nada Elbuluk
Pearl Grimes
Anna Chien
Iltefat Hamzavi
Andrew Alexis
Susan Taylor
Noelani Gonzalez
Jonathan Weiss
Seemal R. Desai
Sewon Kang
Publikationsdatum
01.09.2021
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 6/2021
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-021-00633-4

Weitere Artikel der Ausgabe 6/2021

American Journal of Clinical Dermatology 6/2021 Zur Ausgabe

Acknowledgement to Referees

Acknowledgement to Referees

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.